TITLE

Cerebrovascular Complications of Diabetes: Focus on Stroke

AUTHOR(S)
Ergul, Adviye; Kelly-Cobbs, Aisha; Abdalla, Maha; C. Fagan, Susan
PUB. DATE
June 2012
SOURCE
Endocrine, Metabolic & Immune Disorders - Drug Targets;Jun2012, Vol. 12 Issue 2, p148
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cerebrovascular complications make diabetic patients 2-6 times more susceptible to a stroke event and this risk is magnified in younger individuals and in patients with hypertension and complications in other vascular beds. In addition, when patients with diabetes and hyperglycemia experience an acute ischemic stroke they are more likely to die or be severely disabled and less likely to benefit from the one FDA-approved therapy, intravenous tissue plasminogen activator. Experimental stroke models have revealed that chronic hyperglycemia leads to deficits in cerebrovascular structure and function that may explain some of the clinical observations. Increased edema, neovascularization and protease expression as well as altered vascular reactivity and tone may be involved and point to potential therapeutic targets. Further study is needed to fully understand this complex disease state and the breadth of its manifestation in the cerebrovasculature.
ACCESSION #
75179757

 

Related Articles

  • C Reactive Protein in Acute Ischemic Stroke Patients in Tribhuvan UniversityTeaching Hospital. Rajbhandari, Reema; Gajurel, Bikram; Dhungana, Krishna; Oli, Krishna K. // Nepal Journal of Neuroscience;2014, Vol. 11 Issue 1, p4 

    Introduction: At the time when tissue plasminogen activator and time factor is discussed in ischaemic stroke we have tried to study the level of CRP in these patients. Can it be an investigative tool for screening high-risk patients like diabetes and hypertension is still to be studied. Methods:...

  • Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis. Poppe, Alexandre Y.; Majumdar, Sumit R.; Jeerakathil, Thomas; Ghali, William; Buchan, Alastair M.; Hill, Michael D. // Diabetes Care;Apr2009, Vol. 32 Issue 4, p617 

    OBJECTIVE -- Admission hyperglycemia has been associated with worse outcomes in ischemic stroke. We hypothesized that hyperglycemia (glucose >8.0 mmol/l) in the hyperacute phase would be independently associated with increased mortality, symptomatic intracerebral hemorrhage (SICH), and poor...

  • Ask the Experts. Use of Tissue Plasminogen Activator to Treat Acute Ischemic Stroke. Alexandrov, Anne W. // Critical Care Nurse;Oct2010, Vol. 30 Issue 5, p77 

    The article provides an answer to a question on the use of tissue plasminogen activator to treat acute ischemic stroke.

  • Endovascular Therapies Do Not Improve Outcomes in Acute Stroke. EBELL, MARK H. // American Family Physician;7/1/2013, Vol. 88 Issue 1, following p58 

    The article provides an answer to a question on the effect of adding endovascular procedures to intravenous tissue plasminogen on the outcome of stroke patients.

  • Who should treat stroke? Sacks, David // Journal of NeuroInterventional Surgery;Jan2012, Vol. 4 Issue 1, p7 

    The author emphasizes the need to train physicians to perform interventions for stroke victims. He cites the reasons for the objections to interventional radiologists (IR) treating stroke. He says that intra-arterial (IA) stroke treatment is not investigational. The author argues that training...

  • microRNAs in Stroke Pathogenesis. Tan, J. R.; Koo, Y. X.; Kaur, P.; Liu, F.; Armugam, A.; Wong, P. T. -H.; Jeyaseelan, K. // Current Molecular Medicine;Mar2011, Vol. 11 Issue 2, p76 

    Stroke is one of the leading causes of death and disability worldwide. There are two major types of stroke: cerebral ischemia caused by obstruction of blood vessels in the brain and haemorrhagic stroke that is triggered by the disruption of blood vessels. Thrombolytic therapy involving...

  • A STRIKE AGAINST STROKE. LIEBMAN, BONNIE // Nutrition Action Health Letter;Nov2012, Vol. 39 Issue 9, p1 

    The article offers information on the factors that will and will not lower the risk of a stroke. Medicine professor explains the consequences of a ruptured plaque in blood vessels in the brain, neck or near the heart. Another significant predictor of stroke is transient ischemic stroke, which...

  • The Impact of Diabetes Mellitus on In-hospital Stroke Mortality. Hamidon, B. B.; Raymond, A. A. // Journal of Postgraduate Medicine;Oct-Dec2003, Vol. 49 Issue 4, p307 

    BACKGROUND AND PURPOSE: Diabetes mellitus is a strong risk factor for stroke. However, the prognosis in terms of mortality after a stroke is still unclear, especially in diabetic patients. The main purpose of this study was to compare and evaluate the features of stroke in patients having...

  • Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.  // Current Medical Literature: Stroke Review;2003, Vol. 7 Issue 2, p56 

    Studies arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Assessment using transcranial Doppler after thrombolysis for acute ischemic stroke; Definition of reocclusion.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics